Collectively, the comparable efficacy of C-PC and FPS-ZM1 across multiple mechanistic endpoints underscores that C-PC functions as a natural, multitarget modulator of the AGE–RAGE axis, offering both mechanistic relevance and translational promise for the prevention or attenuation of diabetes-associated neurodegeneration. The gene discussed is AGER; the disease is diabetes mellitus.